68
Views
13
CrossRef citations to date
0
Altmetric
Review

Targeted treatment of acute myeloid leukemia in older adults: role of gemtuzumab ozogamicin

&
Pages 197-205 | Published online: 05 May 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Anna Martner, Fredrik B Thorén, Johan Aurelius, Jonas Söderholm, Mats Brune & Kristoffer Hellstrand. (2010) Immunotherapy with histamine dihydrochloride for the prevention of relapse in acute myeloid leukemia. Expert Review of Hematology 3:4, pages 381-391.
Read now

Articles from other publishers (12)

Sameh Nassar, Gregory P. Kaufman, Ahmed Taher, John E. Madewell & Bilal Mujtaba. 2023. Oncologic Imaging : a Multidisciplinary Approach. Oncologic Imaging : a Multidisciplinary Approach 503 528 .
Kinga Panuciak, Mikołaj Margas, Karolina Makowska & Monika Lejman. (2022) Insights into Modern Therapeutic Approaches in Pediatric Acute Leukemias. Cells 11:1, pages 139.
Crossref
Khalil Saleh, Nadine Khalifeh-Saleh & Hampig Raphael Kourie. (2020) Acute myeloid leukemia transformed to a targetable disease. Future Oncology 16:14, pages 961-972.
Crossref
Sreeraj G. Pillai, Shunqiang Li, Chidananda M. Siddappa, Matthew J Ellis, Mark A. Watson & Rebecca Aft. (2018) Identifying biomarkers of breast cancer micrometastatic disease in bone marrow using a patient-derived xenograft mouse model. Breast Cancer Research 20:1.
Crossref
Yimamu Maimaitili, Aki Inase, Yoshiharu Miyata, Akihito Kitao, Yu Mizutani, Seiji Kakiuchi, Yohei Shimono, Yasuyuki Saito, Takashi Sonoki, Hironobu Minami & Hiroshi Matsuoka. (2018) An mTORC1/2 kinase inhibitor enhances the cytotoxicity of gemtuzumab ozogamicin by activation of lysosomal function. Leukemia Research 74, pages 68-74.
Crossref
Hanna J. Khoury, Robert H. CollinsJrJr, William Blum, Patrick S. Stiff, Laurence Elias, Jane S. Lebkowski, Anita Reddy, Kevin P. Nishimoto, Debasish Sen, Edward D. WirthIIIIII, Casey C. Case & John F. DiPersio. (2017) Immune responses and long-term disease recurrence status after telomerase-based dendritic cell immunotherapy in patients with acute myeloid leukemia. Cancer 123:16, pages 3061-3072.
Crossref
Valeria D’Argenio, Mauro Petrillo, Daniela Pasanisi, Caterina Pagliarulo, Roberta Colicchio, Adelfia Talà, Maria Stella de Biase, Mario Zanfardino, Emanuela Scolamiero, Chiara Pagliuca, Antonio Gaballo, Annunziata Gaetana Cicatiello, Piergiuseppe Cantiello, Irene Postiglione, Barbara Naso, Angelo Boccia, Miriana Durante, Luca Cozzuto, Paola Salvatore, Giovanni Paolella, Francesco Salvatore & Pietro Alifano. (2016) The complete 12 Mb genome and transcriptome of Nonomuraea gerenzanensis with new insights into its duplicated “magic” RNA polymerase. Scientific Reports 6:1.
Crossref
Takahiro Yamauchi, Yasufumi Matsuda, Toshiki Tasaki, Eiju Negoro, Satoshi Ikegaya, Kazutaka Takagi, Akira Yoshida, Yoshimasa Urasaki & Takanori Ueda. (2012) Induction of DNA strand breaks is critical to predict the cytotoxicity of gemtuzumab ozogamicin against leukemic cells. Cancer Science 103:9, pages 1722-1729.
Crossref
Tamara Miner Haygood, Edith M. Marom & Donna M. Weber. 2012. Oncologic Imaging: A Multidisciplinary Approach. Oncologic Imaging: A Multidisciplinary Approach 509 529 .
Rong-guang Shao & Yong-su Zhen. 2012. Recent Advances in Cancer Research and Therapy. Recent Advances in Cancer Research and Therapy 153 171 .
Andrei Turtoi, Edwin De Pauw & Vincent Castronovo. (2011) Innovative Proteomics for the Discovery of Systemically Accessible Cancer Biomarkers Suitable for Imaging and Targeted Therapies. The American Journal of Pathology 178:1, pages 12-18.
Crossref
Jan W. Gratama, Cor H. J. Lamers & Reno Debets. 2011. Principles of Immunopharmacology. Principles of Immunopharmacology 151 178 .